Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Teligent Inc. TLGTQ

Healthcare Drug Manufacturers - Specialty & Generic
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like... see more

Recent & Breaking News (EXPM:TLGTQ)

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

GlobeNewswire May 1, 2018

Mid-Afternoon Market Update: Badger Meter Falls On Earnings Miss; Seadrill Shares Surge

Benzinga.com  April 18, 2018

Mid-Morning Market Update: Markets Mostly Lower; Morgan Stanley Profit Tops Views

Benzinga.com  April 18, 2018

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%

GlobeNewswire April 17, 2018

Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%

GlobeNewswire April 6, 2018

7 Biotech Movers To Watch Today: Prothena, Proteostasis, Global Blood Therapeutics And More

Benzinga.com  March 21, 2018

Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%

GlobeNewswire March 21, 2018

Mid-Afternoon Market Update: Crude Oil Up 2%; Amyris Shares Surge Following Q4 Results

Benzinga.com  March 16, 2018

Mid-Morning Market Update: Markets Open Higher; Buckle Profit Tops Expectations

Benzinga.com  March 16, 2018

Teligent, Inc. Announces Fourth Quarter and Year End 2017 Results

GlobeNewswire March 15, 2018

Teligent, Inc. to Host Earnings Call

Accesswire March 15, 2018

Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018

GlobeNewswire March 13, 2018

Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018

GlobeNewswire March 5, 2018

Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer

GlobeNewswire January 26, 2018

Teligent, Inc. to Present at the J.P. Morgan 36th Annual Healthcare Conference January 10th

GlobeNewswire January 3, 2018

Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%

GlobeNewswire November 22, 2017

Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%

GlobeNewswire November 21, 2017

Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%

GlobeNewswire November 10, 2017

Mid-Afternoon Market Update: Red Robin Drops On Earnings Miss; Myomo Shares Spike Higher

Benzinga.com  November 7, 2017

Mid-Day Market Update: U.S. Stocks Turn Lower; Kindred Healthcare Shares Rise After Q3 Results

Benzinga.com  November 7, 2017